Healthy diet may raise lung cancer risk

A study designed to investigate why lung cancer incidence has increased among younger nonsmokers over the past few decades yielded a surprising observation.
Data from nearly 200 people diagnosed with lung cancer prior to age 40 revealed they adhered to a healthier diet than the general U.S. population.
The finding suggests an environmental risk factor — possibly residue from pesticides used to protect commercially produced crops from disease, weeds or pests — could be contributing to the trend, Jorge Nieva, MD, medical oncologist and lung cancer specialist at USC Norris Comprehensive Cancer

Gamified incentives help walking, not symptoms in osteoarthritis

A game-based behavioral incentive program targeting physical activity improved walking outcomes but failed to improve symptoms in knee osteoarthritis, according to findings published in Arthritis & Rheumatology.
“Exercise is one of the most widely discussed treatments for knee osteoarthritis, but it is hard to motivate people to exercise,” Joshua F. Baker, MD, MSCE, of the Corporal Michael J. Crescenz VA Medical Center and the University of Pennsylvania, in Philadelphia, told Healio. “We hoped to use behavioral incentives to promote more walking and aimed to evaluate

Rectal cancer is striking earlier and killing faster

Rectal cancer deaths among older millennials are accelerating, with growth in mortality far outpacing colon cancer, suggesting primary care doctors should fully investigate early symptoms in patients under age 45, according to a study to be presented at Digestive Disease Week (DDW 2026).

Ultra-processed foods damage your focus even if you eat healthily

New research from Monash University, the University of São Paulo and Deakin University shows that a diet high in heavily processed foods can negatively impact the brain's ability to focus and increases the risk of developing dementia. The study published in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, examined the diets and cognitive health of more than 2,100 Australian dementia-free adults middle-aged and older.

FLAG-based regimen delivers strong outcomes in subtype of acute myeloid leukemia

A new analysis by researchers at The University of Texas MD Anderson Cancer Center demonstrates that a combination therapy consisting of fludarabine, cytarabine and G-CSF (FLAG) plus gemtuzumab ozogamicin (GO) or idarubicin (IDA) continues to deliver strong long-term outcomes for patients with core-binding factor acute myeloid leukemia (CBF-AML), a subtype of the disease involving a chromosomal rearrangement.